Optimal markers of treatment response to vasodilatory drugs in small vessel disease: An OxHARP Trial analysis. Webb A, Feakins KA, Lawson A, Stewart C, et al. Int J Stroke 2025 Jul 10:17474930251360093. doi: 10.1177/17474930251360093.

Read + Share

Amedeo Smart

Independent Medical Education

Webb A, Feakins KA, Lawson A, Stewart C, et al. Optimal markers of treatment response to vasodilatory drugs in small vessel disease: An OxHARP Trial analysis. Int J Stroke 2025 Jul 10:17474930251360093. doi: 10.1177/17474930251360093.
PMID: 40641043